Prostaglandin E2 induces transcription of skeletal muscle mass regulators interleukin-6 and muscle RING finger-1 in humans

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 5, 2013, Pages 361-364

  Standley, R A ^a   Liu, S Z ^a   Jemiolo, B ^a   Trappe, S W ^a   Trappe, T A ^a  

^a BALL STATE UNIVERSITY   (United States)

Author keywords

IL 6; MuRF 1; PGE2; Skeletal muscle

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; MUSCLE PROTEIN; TRIM63 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERLEUKIN 6 GENE; MALE; MOLECULAR DYNAMICS; MUSCLE BIOPSY; MUSCLE MASS; MUSCLE RING FINGER 1 PROTEIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; UPREGULATION;

ADULT; DINOPROSTONE; HUMANS; INTERLEUKIN-6; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 84877609544     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.02.004     Document Type: Article

References (43)

1. 2α influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 1982, 257:1632-1638.
2. 2 in response to eccentric resistance exercise: influence of ibuprofen and acetaminophen. J. Clin. Endocrinol. Metab. 2001, 86:5067-5070.
3. Trappe T.A., White F., Lambert C.P., Cesar D., Hellerstein M., Evans W.J. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E551-E556.
4. Palmer R.M. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot. Essent. Fatty Acids 1990, 39:95-104.
5. 2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy. Am. J. Physiol. Cell Physiol. 2011, 300:C671-C682.
6. Trappe T.A., Carroll C.C., Dickinson J.M., LeMoine J.K., Haus J.M., Sullivan B.E., Lee J.D., Jemiolo B., Weinheimer E.M., Hollon C.J. Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R655-R662.
7. Trappe T.A., Standley R.A., Jemiolo B., Carroll C.C., Trappe S.W. Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304:R198-R205.
8. van Hall G., Steensberg A., Fischer C., Keller C., Moller K., Moseley P., Pedersen B.K. Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J. Clin. Endocrinol. Metab. 2008, 93:2851-2858.
9. Barbieri M., Ferrucci L., Ragno E., Corsi A., Bandinelli S., Bonafe M., Olivieri F., Giovagnetti S., Franceschi C., Guralnik J.M., Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E481-E487.
10. de Gonzalo-Calvo D., de Luxan-Delgado B., Rodriguez-Gonzalez S., Garcia-Macia M., Suarez F.M., Solano J.J., Rodriguez-Colunga M.J., Coto-Montes A. Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach. Cytokine 2012, 58:193-198.
11. Ferrucci L., Harris T.B., Guralnik J.M., Tracy R.P., Corti M.C., Cohen H.J., Penninx B., Pahor M., Wallace R., Havlik R.J. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 1999, 47:639-646.
12. Schaap L.A., Pluijm S.M., Deeg D.J., Harris T.B., Kritchevsky S.B., Newman A.B., Colbert L.H., Pahor M., Rubin S.M., Tylavsky F.A., Visser M. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J. Gerontol. 2009, 64:1183-1189.
13. Bodell P.W., Kodesh E., Haddad F., Zaldivar F.P., Cooper D.M., Adams G.R. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J. Appl. Physiol. 2009, 106:443-453.
14. Haddad F., Zaldivar F., Cooper D.M., Adams G.R. IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 2005, 98:911-917.
15. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
16. Sacheck J.M., Hyatt J.P., Raffaello A., Jagoe R.T., Roy R.R., Edgerton V.R., Lecker S.H., Goldberg A.L. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 2007, 21:140-155.
17. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 2008, 23:160-170.
18. Dendorfer U., Oettgen P., Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 1994, 14:4443-4454.
19. 2 induces interleukin-6 synthesis in human astrocytoma cells. J. Neurochem. 1997, 68:704-709.
20. 2 in the synthesis of the pro-inflammatory cytokine interleukin-6 in primary sensory neurons: an in vivo and in vitro study. J. Neurochem. 2011, 118:841-854.
21. 2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation. Am. J. Physiol. Cell Physiol. 2010, 298:C1445-C1456.
22. Delmonico M.J., Harris T.B., Lee J.S., Visser M., Nevitt M., Kritchevsky S.B., Tylavsky F.A., Newman A.B. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J. Am. Geriatr. Soc. 2007, 55:769-774.
23. Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., Abellan van Kan G., Andrieu S., Bauer J., Breuille D., Cederholm T., Chandler J., De Meynard C., Donini L., Harris T., Kannt A., Keime Guibert F., Onder G., Papanicolaou D., Rolland Y., Rooks D., Sieber C., Souhami E., Verlaan S., Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 2011, 12:249-256.
24. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002, 50:889-896.
25. Bergstrom J. Muscle electrolytes in man. Scand. J. Clin Lab. Invest. 1962, 14:7-110.
26. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand. J. Clin. Lab. Invest. 1975, 35:609-616.
27. Fiebich B.L., Schleicher S., Spleiss O., Czygan M., Hull M. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 2001, 79:950-958.
28. 2. PLoS One 2011, 6:e27630.
29. Louis E., Raue U., Yang Y., Jemiolo B., Trappe S. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J. Appl. Physiol. 2007, 103:1744-1751.
30. Weinheimer E.M., Jemiolo B., Carroll C.C., Harber M.P., Haus J.M., Burd N.A., Lemoine J.K., Trappe S.W., Trappe T.A. Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R2241-R2248.
31. Burd N.A., Dickinson J.M., Lemoine J.K., Carroll C.C., Sullivan B.E., Haus J.M., Jemiolo B., Trappe S.W., Hughes G.M., Sanders C.E., Trappe T.A. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E354-E361.
32. Jemiolo B., Trappe S. Single muscle fiber gene expression in human skeletal muscle: validation of internal control with exercise. Biochem. Biophys. Res. Commun. 2004, 320:1043-1050.
33. Raue U., Slivka D., Jemiolo B., Hollon C., Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:1407-1412.
34. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
35. Dickinson J.M., Lee J.D., Sullivan B.E., Harber M.P., Trappe S.W., Trappe T.A. A new method to study in vivo protein synthesis in slow- and fast-twitch muscle fibers and initial measurements in humans. J. Appl. Physiol. 2010, 108:1410-1416.
36. Henriksson J., Reitman J.S. Quantitative measures of enzyme activities in type I and type II muscle fibres of man after training. Acta Physiol. Scand. 1976, 97:392-397.
37. Raue U., Trappe T.A., Estrem S.T., Qian H.R., Helvering L.M., Smith R.C., Trappe S. Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J. Appl. Physiol. 2012, 112:1625-1636.
38. Saltin B., Gollnick P.D. Skeletal muscle adaptability: significance for metabolism and performance. Handbook of Physiology-Skeletal Muscle 1983, 555-631. American Physiological Society, Bethesda, MD. L.D. Peachey, R.H. Adrian, S.R. Geiger (Eds.).
39. Yang Y., Jemiolo B., Trappe S. Proteolytic mRNA expression in response to acute resistance exercise in human single skeletal muscle fibers. J. Appl. Physiol. 2006, 101:1442-1450.
40. Hiscock N., Chan M.H., Bisucci T., Darby I.A., Febbraio M.A. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J. 2004, 18:992-994.
41. Wang P., Zhu F., Lee N.H., Konstantopoulos K. Shear-induced interleukin-6 synthesis in chondrocytes: roles of E prostanoid (EP) 2 and EP3 in cAMP/protein kinase A- and PI3-K/Akt-dependent NF-kappaB activation. J. Biol. Chem. 2010, 285:24793-24804.
42. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., Hasselgren P.O., Frontera W.R., Lee J., Glass D.J., Shoelson S.E. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004, 119:285-298.
43. Vella L., Caldow M.K., Larsen A.E., Tassoni D., Della Gatta P.A., Gran P., Russell A.P., Cameron-Smith fD. Resistance exercise increases NF-kappaB activity in human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R667-R673.